ÂÜÀòÂÒÂ×

Suzanne Coles has a diverse and extensive work experience in the pharmaceutical and healthcare industry. Suzanne started their career at Datamonitor as a Senior Consultant and Regional Lead in France. Suzanne then worked at Salomon Smith Barney Holdings Inc. as a Senior Financial Analyst in the Pharmaceutical and Healthcare Franchise Team. Following that, Suzanne joined Gemini Consulting Partners as the Principal and Head of Global Life Sciences Strategic Research. Suzanne later joined Edengene as an Associate Partner and the Head of Life Sciences Practice. Suzanne then worked at Eden McCallum as an Independent Consultant and at Shiloh Advisors as a Principal Consultant in the European Strategy and Innovation Practice. Suzanne also held the role of Delligent Technology Medical Franchise Head at Adiuvo Investments S.A. In 2013, Suzanne joined a-connect as an Independent Professional, where they worked on various strategic planning and business development roles for top-tier pharmaceutical and biotechnology companies. Most recently, Suzanne is currently working at GSD Health as the Clinical and Development Lead.

Suzanne Coles has a diverse education history. Suzanne obtained a Masters degree in Artificial Intelligence from the MIT Sloan School of Management in 2022. In 1993, they completed their MA degree from the University of Cambridge. Suzanne also pursued a Masters degree in Environmental Chemistry from The Open University, focusing on Biochemistry and Molecular Biology. Although specific dates are not provided, Suzanne has pursued additional studies and certifications, including participating in the AI Startups & Innovation Programme at Imperial College London. It is mentioned that Suzanne has a Doctor of Philosophy degree (PhD) in Applied Neurosciences from King's College London, however, the start and end years are not mentioned. Suzanne has also shown interest in Artificial Intelligence by studying it further at Saïd Business School, University of Oxford, although the specific degree is not specified.